Announce Date | 07/18/2025 |
EPS Normalized Actual | $2.16 (Beat by $0.09) |
EPS GAAP Actual | $2.16 (Beat by $0.09) |
Revenue Actual | $2.714B |
Revenue Surprise | Beat by $2714M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.84667 |
EPS GAAP Estimate | $2.84667 |
Revenue Estimate | $2.9085B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 14.088 | 7.83 | 13.46228 | 14.84439 | 1 |
Dec 2028 | 14.5 | 7.6 | 14.01181 | 15.01186 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.17 | -0.57008 | 2.714B | 4.02% | -161.1M |
FQ1 2025 (Mar 2025) | 2.15 | 0.07307 | 2.578B | -1.44% | -193.1M |
FQ4 2024 (Dec 2024) | 3.03 | -0.16869 | 2.616B | -5.16% | -220.6M |
FQ3 2024 (Sep 2024) | 1.74 | 1.74 | 2.555B | -1.6% | 2555M |
FQ2 2024 (Jun 2024) | 1.71 | 1.71 | 2.605B | -1.15% | 2605M |
FQ1 2024 (Mar 2024) | 1.53 | 1.53 | 2.615B | 4.67% | 2615M |
FQ4 2023 (Dec 2023) | 2.72 | 2.72 | 2.751B | 100% | 2751M |
FQ3 2023 (Sep 2023) | 1.58 | 1.58 | 2.596B | 100% | 2596M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.84667
Consensus Revenue Estimates
2.9085B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.53 | -- | 3.53 | 3.53 | 5 |
FQ3 2027 (Sep 2027) | 2.78 | -- | 2.78 | 2.78 | 5 |
FQ2 2027 (Jun 2027) | 2.99 | -- | 2.99 | 2.99 | 5 |
FQ1 2027 (Mar 2027) | 2.82 | -- | 2.82 | 2.82 | 5 |
FQ4 2026 (Dec 2026) | 3.58 | -- | 3.49333 | 3.66667 | 1 |
FQ3 2026 (Sep 2026) | 3.06 | -- | 2.98592 | 3.13408 | 1 |
FQ2 2026 (Jun 2026) | 2.98 | 27.18 | 2.90786 | 3.05214 | 1 |
FQ1 2026 (Mar 2026) | 2.47 | 12.96 | 2.4102 | 2.5298 | 1 |
FQ4 2025 (Oct 2025) | 3.08667 | 1.84 | 3.00558 | 3.15447 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.36B | -- | 3.36B | 3.36B | 6 |
FQ3 2027 (Sep 2027) | 3.29B | -- | 3.29B | 3.29B | 6 |
FQ2 2027 (Jun 2027) | 3.22B | -- | 3.22B | 3.22B | 6 |
FQ1 2027 (Mar 2027) | 3.15B | -- | 3.15B | 3.15B | 6 |
FQ4 2026 (Dec 2026) | 2.91B | -- | 2.85B | 2.96B | 1 |
FQ3 2026 (Sep 2026) | 2.86B | -- | 2.81B | 2.92B | 1 |
FQ2 2026 (Jun 2026) | 2.82B | 3.89 | 2.77B | 2.88B | 1 |
FQ1 2026 (Mar 2026) | 2.78B | 7.39 | 2.73B | 2.84B | 1 |
FQ4 2025 (Oct 2025) | 2.94B | 10.95 | 2.88B | 2.99B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.74008 | 2.17 | -0.57008 | -26.27% |
FQ1 2025 (Mar 2025) | 2.07693 | 2.15 | 0.07307 | 3.4% |
FQ4 2024 (Dec 2024) | 3.19869 | 3.03 | -0.16869 | -5.57% |
FQ3 2024 (Sep 2024) | 1.74 | 1.74 | 100% | |
FQ2 2024 (Jun 2024) | 1.71 | 1.71 | 100% | |
FQ1 2024 (Mar 2024) | 1.53 | 1.53 | 100% | |
FQ4 2023 (Dec 2023) | 2.72 | 2.72 | 100% | |
FQ3 2023 (Sep 2023) | 1.58 | 1.58 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $2.88B | $2.71B | $-161.1M | -5.94% |
FQ1 2025 (Mar 2025) | $2.77B | $2.58B | $-193.1M | -7.49% |
FQ4 2024 (Dec 2024) | $2.84B | $2.62B | $-220.6M | -8.43% |
FQ3 2024 (Sep 2024) | $0B | $2.56B | $2555M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.61B | $2605M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.62B | $2615M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.75B | $2751M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.6B | $2596M | 100% |